Based on these findings, it has been proposed that a combination of D2 antagonistic and 5-HT1A agonistic properties would offer additional advantages in treating some mental disorders, such as anxiety, depression (for fast onset anti-depressants) and schizophrenia [50, 51]. This evidence concerns the gene HTR1A and depressive disorder.